| Authors: |
Dere E; Department of Safety Assessment, 7412Genentech Inc., South San Francisco, CA, USA., Crowell S; Department of Preclinical and Translational Pharmacokinetics and Pharmacodynamics, 7412Genentech Inc., South San Francisco, CA, USA., Maia M; Department of Bioanalytical Sciences, 7412Genentech Inc., South San Francisco, CA, USA., Schuetz C; Department of Safety Assessment, 7412Genentech Inc., South San Francisco, CA, USA., Lai P; Department of Early Clinical Development OMNI, 7412Genentech Inc., South San Francisco, CA, USA., Bantseev V; Department of Safety Assessment, 7412Genentech Inc., South San Francisco, CA, USA., Booler H; Department of Safety Assessment, 7412Genentech Inc., South San Francisco, CA, USA.; Department of BIOmics and Pathology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland. |
